Search

Displaying results 9101 - 9110 of 10000 in total
  1. Drug

    Branebrutinib

    go.drugbank.com/drugs/DB15347
    Investigational

    Branebrutinib is under investigation in clinical trial NCT02705989 (Safety, Tolerability and Relative Bioavailability Study of BMS-986195 in Healthy Subjects).

  2. Drug

    Leptazoline A

    go.drugbank.com/drugs/DB15551
    Experimental

    Also see [Leptazoline B], [Leptazoline C], and [Leptazoline D].

  3. Drug

    Leptazoline B

    go.drugbank.com/drugs/DB15552
    Experimental

    Also see [Leptazoline A], [Leptazoline C], and [Leptazoline D].

  4. Drug

    Leptazoline C

    go.drugbank.com/drugs/DB15553
    Experimental

    Also see [Leptazoline A], [Leptazoline B], and [Leptazoline D].

  5. Drug

    GSK-364735

    go.drugbank.com/drugs/DB13119
    Investigational

    GSK-364735 (Naphthyridinone) has been used in trials studying the treatment of HIV-1 Infection and Infection, Human Immunodeficiency Virus.

  6. Drug

    Nedisertib

    go.drugbank.com/drugs/DB16252
    Investigational

    Nedisertib is under investigation in clinical trial NCT03770689 (Study of M3814 in Combination With Capecitabine and Radiotherapy in Rectal Cancer).

  7. Drug

    SerpinPC

    go.drugbank.com/drugs/DB17698
    Investigational

    SerpinPC is a mutated alpha-1-antitrypsin (α1AT) and serine protease inhibitor being investigated for the treatment of hemophilia.[A258993]

  8. Drug

    UV1

    go.drugbank.com/drugs/DB18470
    Experimental

    UV1 is a cancer vaccine consisting of p719-20, p728, and p725 synthetic peptides representing fragments of the hTERT subunit

  9. Drug

    FCR001

    go.drugbank.com/drugs/DB18595
    Investigational

    FCR001 is a somatic cell therapy product containing hematopoietic progenitor cells (HPC), Facilitating Cells (FC), and alpha beta T cells.

  10. Drug

    Zeluvalimab

    go.drugbank.com/drugs/DB18868
    Investigational

    Zeluvalimab is under investigation in clinical trial NCT04631601 (Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (Mcrpc)).